XML 70 R54.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
May 04, 2020
Oct. 01, 2019
Jul. 07, 2019
Aug. 27, 2018
Dec. 31, 2022
Jul. 31, 2022
Apr. 30, 2022
Mar. 31, 2021
Feb. 28, 2021
Dec. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Apr. 04, 2022
Loss Contingencies [Line Items]                          
Royalty expense                     $ 1,771,219 $ 856,755  
Royalty payments                   $ 50,250 201,000    
Cash $ 500,000                        
Annual royalty obligation                   $ 4,020 $ 16,080    
Accredited investors shares             165,738            
Transaction expenses             $ 600,000            
Share price             $ 30.75           $ 30.75
Options to acquire shares             144,191       144,191    
Weighted exercise price             $ 10.71            
Warrants to purchase shares             4,424            
Exercise price             $ 7.32            
Expiration date             Apr. 22, 2031            
Cash consideration           $ 10,000,000.0              
Number of shares           486,145              
Net income                     $ (154,831) $ (71,881)  
Common Stock [Member]                          
Loss Contingencies [Line Items]                          
Accredited investors shares                     457,424    
Warrants to purchase shares             12,301            
Exercise price             $ 12.05            
Expiration date             Aug. 10, 2030            
Issuance of common stock in equity offering, shares                       1,265,000  
Precision Healing Inc [Member]                          
Loss Contingencies [Line Items]                          
Cash consideration             $ 125,966            
2009 [Member] | Resorbable Bone Hemostat [Member]                          
Loss Contingencies [Line Items]                          
Royalty percentage                     2.00%    
Royalty payments                     $ 201,000    
Rochal Industries LLC [Member]                          
Loss Contingencies [Line Items]                          
Issuance of common stock in equity offering, shares               20,834 20,834        
Precision Healing [Member]                          
Loss Contingencies [Line Items]                          
Share price $ 27.13                        
Payments receive $ 10,000,000.0                        
Wound Care Solutions Limited [Member]                          
Loss Contingencies [Line Items]                          
Net income         $ 242,000   $ 220,000       200,000    
Wound Care Solutions Limited [Member] | 2021 Through 2024 [Member]                          
Loss Contingencies [Line Items]                          
Net income, percentage             10.00%            
Sub License Agreement [Member]                          
Loss Contingencies [Line Items]                          
License agreement and royalties description       In August 2018, the Company entered an exclusive, world-wide sublicense agreement with CGI Cellerate RX, LLC (“CGI Cellerate RX”) to distribute CellerateRX Surgical and HYCOL products into the surgical and wound care markets. Pursuant to the sublicense agreement, the Company pays royalties of 3-5% of annual collected net sales of CellerateRX Surgical and HYCOL. As amended in January 2021, the term of the sublicense extends through May 2050, with automatic successive year-to-year renewal terms thereafter so long as the Company’s Net Sales (as defined in the sublicense agreement) each year are equal to or in excess of $1,000,000. If the Company’s Net Sales fall below $1,000,000 for any year after the initial expiration date, CGI Cellerate RX will have the right to terminate the sublicense agreement upon written notice.                  
BIAKOS License Agreement [Member]                          
Loss Contingencies [Line Items]                          
Royalty expense                     $ 120,000 $ 110,000  
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member]                          
Loss Contingencies [Line Items]                          
Royalty payments     $ 120,000                    
Royalties payable     10,000                    
Maximum amount of royalty     $ 150,000                    
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Minimum [Member]                          
Loss Contingencies [Line Items]                          
Royalty percentage     2.00%                    
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Maximum [Member]                          
Loss Contingencies [Line Items]                          
Royalty percentage     4.00%                    
BIAKOS Agreement [Member]                          
Loss Contingencies [Line Items]                          
Royalty payments     $ 1,000,000                    
ABF License Agreement [Member]                          
Loss Contingencies [Line Items]                          
Royalty payments   $ 50,000                      
Maximum amount of royalty   $ 75,000                      
Royalty annual minimum percentage   10.00%                      
ABF License Agreement [Member] | Minimum [Member]                          
Loss Contingencies [Line Items]                          
Royalty percentage   2.00%                      
ABF License Agreement [Member] | Maximum [Member]                          
Loss Contingencies [Line Items]                          
Royalty percentage   4.00%                      
Royalty payments   $ 500,000                      
Debrider License Agreement [Member]                          
Loss Contingencies [Line Items]                          
Royalty payments 1,000,000                        
Maximum amount of royalty $ 150,000                        
Royalty annual minimum percentage 10.00%                        
Payments for royalty $ 1,000                        
Debrider License Agreement [Member] | Minimum [Member]                          
Loss Contingencies [Line Items]                          
Royalty percentage 2.00%                        
Debrider License Agreement [Member] | Maximum [Member]                          
Loss Contingencies [Line Items]                          
Royalty percentage 4.00%                        
Royalty Agreement [Member] | 2009 [Member] | Resorbable Bone Hemostat [Member]                          
Loss Contingencies [Line Items]                          
Royalty annual minimum percentage                     8.00%    
Purchase Agreement [Member]                          
Loss Contingencies [Line Items]                          
Cash           $ 1,600,000              
Payments to acquire assets           $ 7,600,000              
Issuance of common stock for purchase of assets           291,686              
Issuance of common stock in equity offering, shares           94,798